1-877-439-2744 Motherisk Helpline
1-800-436-8477 Morning Sickness
1-877-327-4636 Alcohol and Substance
1-866-937-7678 Exercise in Pregnancy
1-888-246-5840 HIV and HIV Treatment
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Amer J Obstet Gynecol 162: 655-660, 1990.
Einarson T, Koren G, Mattice D, Schechter Tsafrisi O: Maternal Spermicide use and adverse reproductive outcome: A meta-analysis.
Obstet Gynecol. 85(1):141-9, 1995 Jan.
Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G: Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis.
Is the fetus safe when spermicides fail?
Extrapolation of findings from reproductive studies in animals to humans